PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / SOLUTIONS

Bio AER procurement for Primary Care

Primary Care purchasing teams can evaluate Bio AER by its listed presentation, current labeling, and lot documentation. Bio AER is listed as a professional-use formulation in a 1 mL vial. The source description does not establish a numerical particle specification or a complete handling schedule. Request written composition and storage details before purchasing.

PROFESSIONAL PERSPECTIVE

Define the purchasing request

Identify the licensed ordering practice, receiving location, and staff responsible for Bio AER documentation. Confirm the requested presentation: 1 mL vial.

Specialty affiliation does not establish an intended use. Keep the procurement review separate from any physician and counsel assessment of a proposed application.

Prepare the receiving file

Request the current insert, lot analysis, release information, and applicable donor eligibility summary before booking a shipment. Confirm handling instructions for the exact SKU.

Document the receiving contact, lot identifier, expiration details, and any discrepancy. An unresolved handling or labeling question should remain open until the supplier provides a written response.

Review scope with counsel

For licensed clinic procurement. This is not a stem cell therapy. No clinical outcome is represented. The ordering physician and clinic counsel must review the current labeling, product classification, and intended use before any purchase or use decision. Account verification does not establish permission for a clinical application.

Record the decision owner and review date. Revisit the file if the label, supplier, product presentation, or intended use changes.

FAQ

Frequently asked questions

What format is listed for Bio AER?+

1 mL vial. Confirm the current label and product-specific instructions before ordering.

Does a Primary Care account establish a permitted application?+

No. Account verification is an administrative procurement step. The physician and clinic counsel must review the intended use.